Comparison of the 99th percentiles of three troponin I assays in a large reference population

Insights

Comparing sensitive troponin assays is crucial. This study found variations in 99th percentiles across assays, with some showing gender differences, highlighting the need for careful assay selection in clinical practice.

Area of Science:

  • Clinical Chemistry
  • Cardiovascular Diagnostics
  • Biomarker Assays

Background:

  • The International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Task Force recommends comparing sensitive troponin assays.
  • A large, healthy reference population is essential for accurate assay evaluation.

Purpose of the Study:

  • To compare three contemporary sensitive troponin I assays.
  • To determine the 99th percentiles for these assays in a large healthy population.
  • To investigate the influence of age and gender on troponin I levels.

Main Methods:

  • Troponin I concentrations were measured using three sensitive assays in 2404 healthy individuals and a subgroup of 908.
  • Quantile regression was employed to calculate the 99th percentiles, accounting for the entire population distribution.
  • Statistical analysis explored age and gender dependencies for each assay.

Main Results:

  • The 99th percentiles were 21 ng/L (ARCHITECT STAT), 31 ng/L (ADVIA Centaur), and 28 ng/L (Dimension Vista).
  • Gender differences in troponin I levels were observed for the Dimension Vista assay and the ARCHITECT assay subgroup.
  • No significant age dependency was found across the assays.

Conclusions:

  • Quantile regression effectively estimates 99th percentiles and their relationship with demographic factors.
  • Assay-specific gender differences exist, necessitating consideration in clinical interpretation.
  • The findings support the IFCC recommendation for comparative assay evaluation.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...